Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Real-World Treatment Patterns and Patient Outcomes in Relapsed/Refractory Hodgkin Lymphoma in the US

Fjoralba Kristo, Melissa Lingohr-Smith, Jay Lin, Ajibade Ashaye

Blood (2023) 142 (Supplement 1): 7347.

https://doi.org/10.1182/blood-2023-174435

Published: 2023

Journal Articles

Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department

Steven Deitelzweig, MD, Patrick Hlavacek, MPH, Jack Mardekian, PhD, Lisa Rosenblatt, MD MPH, Cristina Russ, MD PhD, Kenneth Tuell, RPh, Melissa Lingohr-Smith, PhD, Jay Lin, PhD MBA, Jennifer D Guo, PhD

Blood (2019) 134 (Supplement_1): 2157.

https://doi.org/10.1182/blood-2019-125845

Published: 2019

Journal Articles

The Impact of Chronic Myeloid Leukemia Therapy Management on the Oncology Care Model

Elias J. Jabbour, MD, Martin F Mendiola, MD MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Jay Lin, PhD MBA, Dinara Makenbaeva, MD MBA

Blood (2018) 132 (Supplement 1): 2265.

https://doi.org/10.1182/blood-2018-99-112484

Published: 2018

Journal Articles

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

Alpesh J. Amin, MD MBA, Steven Deitelzweig, MD, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, W. Richey Neuman, MD MPH

Blood (2018) 132 (Supplement 1): 365.

https://doi.org/10.1182/blood-2018-99-112288

Published: 2018

Journal Articles

Impact of Earlier Vs. Later Monitoring on Disease Progression and Economic Outcomes Among Patients with Chronic Myeloid Leukemia in the Real-World Setting

Elias J. Jabbour, MD, Lisa Siegartel, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Dinara Makenbaeva, MD MBA

Blood (2017) 130 (Supplement 1): 2175.

https://doi.org/10.1182/blood.V130.Suppl_1.2175.2175

Published: 2017

Journal Articles

The Frequency of Venous Thromboembolism (VTE) Prophylaxis Among Patients Hospitalized for Cancer in the US

Alpesh J. Amin, MD, Richey Neuman, MD MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Jay Lin, PhD MBA

Blood (2017) 130 (Supplement 1): 4734.

https://doi.org/10.1182/blood.V130.Suppl_1.4734.4734

Published: 2017

Journal Articles

Did Patients with Renal Disease Receive Sufficient Prophylaxis for Venous Thromboembolism in the Real-World Settings?: A Study Among Hospitalized Acutely Medically Ill Patients

Alpesh J. Amin, MD, Richey Neuman, MD MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Jay Lin, PhD MBA

Blood (2017) 130 (Supplement 1): 3416.

https://doi.org/10.1182/blood.V130.Suppl_1.3416.3416

Published: 2017

Journal Articles

Economic Modeling of the Potential Impact of Chronic Myeloid Leukemia (CML) Monitoring on Healthcare Costs

Elias J. Jabbour, MD, Lisa Siegartel, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Dinara Makenbaeva, MD MBA

Blood (2017) 130 (Supplement 1): 3378.

https://doi.org/10.1182/blood.V130.Suppl_1.3378.3378

Published: 2017

Journal Articles

Evaluation of Healthcare Resource Utilization and Costs Among Patients with Chronic Myeloid Leukemia after Disease Progression

Elias Jabbour, MD, Jay Lin, PhD MBA, Lisa R Siegartel, MPH, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, Dinara Makenbaeva, MD MBA

Blood (2016) 128 (22): 3573.

https://doi.org/10.1182/blood.V128.22.3573.3573

Published: 2016

Journal Articles

Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated with Different Outcomes Among Patients with Venous Thromboembolism?

Alex C. Spyropoulos, MD, Ron Preblick, PharmD, MPH, Jackie Kwong, PhD, Melissa Lingohr-Smith, PhD, Jay Lin, PhD MBA

Blood (2015) 126 (23): 1126.

https://doi.org/10.1182/blood.V126.23.1126.1126

Published: 2015

Journal Articles

Hospitalizations and Mortality Associated with dsDNA Viral Infections Among Hematopoietic Cell Transplant Recipients

Essy Mozaffari, PharmD, MPH, MBA, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD

Blood (2015) 126 (23): 2073.

https://doi.org/10.1182/blood.V126.23.2073.2073

Published: 2015

Journal Articles

Economic Burden of Adverse Events Among Patients with Chronic Myelogenous Leukemia Treated with BCR-ABL1 Tyrosine Kinase Inhibitors

Jay Lin, PhD MBA, Makenbaeva Dinara, MD MBA, Bilmes Robyn, PharmD, BCOP, Melissa Lingohr-Smith, PhD, Nicola Wallis, MRCPath, FFPM

Blood (2015) 126 (23): 876.

https://doi.org/10.1182/blood.V126.23.876.876

Published: 2015

Journal Articles

Estimate of Real-World Medical Costs Avoidance When New Oral Anticoagulants Are Used Vs. Standard Therapy for the Treatment of Patients with Venous Thromboembolism in the U.S

Alpesh N Amin, MDMBA, Amanda Bruno, PhD MPH, Jeffrey Trocio, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD

Blood (2014) 124 (21): 687.

https://doi.org/10.1182/blood.V124.21.687.687

Published: 2014

Journal Articles

Comparison of Medical Costs Avoided When New Oral Anticoagulants Are Used for the Treatment of Patients with Atrial Fibrillation and Venous Thromboembolism in the U.S

Alpesh N Amin, MDMBA, Amanda Bruno, PhD MPH, Jeffrey Trocio, MPH, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD

Blood (2014) 124 (21): 2181.

https://doi.org/10.1182/blood.V124.21.2181.2181

Published: 2014

Journal Articles

Evaluation of Comorbidities Relevant to Tyrosine Kinase Inhibitor Treatment Among Patients with Chronic Myelogenous Leukemia in the U.S. Managed Care Setting

Elias Jabbour, MD, Dinara Makenbaeva, MD MBA, Melissa Lingohr-Smith, PhD, Jay Lin, PhD MBA

Blood (2014) 124 (21): 4550.

https://doi.org/10.1182/blood.V124.21.4550.4550

Published: 2014

Journal Articles

Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery

Steven Deitelzweig, MD, Edith A Nutescu, PharmD, MS, James Meyer, PharmD, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Alpesh N Amin, MDMBA

Blood (2014) 124 (21): 4852.

https://doi.org/10.1182/blood.V124.21.4852.4852

Published: 2014

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real-World Treatment Patterns and Patient Outcomes in Relapsed/Refractory Hodgkin Lymphoma in the US

Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department

The Impact of Chronic Myeloid Leukemia Therapy Management on the Oncology Care Model

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

Impact of Earlier Vs. Later Monitoring on Disease Progression and Economic Outcomes Among Patients with Chronic Myeloid Leukemia in the Real-World Setting

The Frequency of Venous Thromboembolism (VTE) Prophylaxis Among Patients Hospitalized for Cancer in the US

Did Patients with Renal Disease Receive Sufficient Prophylaxis for Venous Thromboembolism in the Real-World Settings?: A Study Among Hospitalized Acutely Medically Ill Patients

Economic Modeling of the Potential Impact of Chronic Myeloid Leukemia (CML) Monitoring on Healthcare Costs

Evaluation of Healthcare Resource Utilization and Costs Among Patients with Chronic Myeloid Leukemia after Disease Progression

Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated with Different Outcomes Among Patients with Venous Thromboembolism?

Hospitalizations and Mortality Associated with dsDNA Viral Infections Among Hematopoietic Cell Transplant Recipients

Economic Burden of Adverse Events Among Patients with Chronic Myelogenous Leukemia Treated with BCR-ABL1 Tyrosine Kinase Inhibitors

Estimate of Real-World Medical Costs Avoidance When New Oral Anticoagulants Are Used Vs. Standard Therapy for the Treatment of Patients with Venous Thromboembolism in the U.S

Comparison of Medical Costs Avoided When New Oral Anticoagulants Are Used for the Treatment of Patients with Atrial Fibrillation and Venous Thromboembolism in the U.S

Evaluation of Comorbidities Relevant to Tyrosine Kinase Inhibitor Treatment Among Patients with Chronic Myelogenous Leukemia in the U.S. Managed Care Setting

Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only